ESMO 2026 · LBA20 (Oral)
AI Driven Digital Pathology for the 70 Gene Recurrence Signature: Development and Validation in Early Stage Breast Cancer
Our work at Agendia explores predicting recurrence risk directly from routine whole-slide images of breast cancer tissue, using supervision from the 70-gene signature.

